Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Allez

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Pathologie-Biologie|April 9, 2008
IFNgamma and antibody responses among French nurses during a tuberculosis contact tracing investigationJ-L Herrmann, N Simonney, A Bergeron, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 21, 2015
Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year studyB Denis, M Lafaurie, J-L Donay, et al.
The Journal of Dermatological Treatment|February 20, 2014
Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paperG Girolomoni, C E M Griffiths, J Krueger, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2015
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's diseaseB G Feagan, W J Sandborn, G D'Haens, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 5, 2023
Prognosis and molecular characteristics of IBD-associated colorectal cancer: Experience from a French tertiary-care centerN Hammoudi, J Lehmann-Che, J Lambert, et al.
Gastroenterologie Clinique Et Biologique|February 15, 2002
[Infliximab therapy for Crohn's disease anoperineal lesions]A Ouraghi, S Nieuviarts, J L Mougenel, et al.
Revista De Gastroenterologia De Mexico|March 15, 2015
[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)]A Dignass, J O Lindsay, A Sturm, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodiesM Allez, S Vermeire, N Mozziconacci, et al.
Diagnostic and Interventional Imaging|April 8, 2015
Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging featuresA Dohan, S A Faraoun, M Barral, et al.
La Revue De Medecine Interne|January 14, 2024
French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseasesD Farge, G Pugnet, M Allez, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Pathologie-Biologie|April 9, 2008
IFNgamma and antibody responses among French nurses during a tuberculosis contact tracing investigationJ-L Herrmann, N Simonney, A Bergeron, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|July 21, 2015
Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year studyB Denis, M Lafaurie, J-L Donay, et al.
The Journal of Dermatological Treatment|February 20, 2014
Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paperG Girolomoni, C E M Griffiths, J Krueger, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2015
Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's diseaseB G Feagan, W J Sandborn, G D'Haens, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 5, 2023
Prognosis and molecular characteristics of IBD-associated colorectal cancer: Experience from a French tertiary-care centerN Hammoudi, J Lehmann-Che, J Lambert, et al.
Gastroenterologie Clinique Et Biologique|February 15, 2002
[Infliximab therapy for Crohn's disease anoperineal lesions]A Ouraghi, S Nieuviarts, J L Mougenel, et al.
Revista De Gastroenterologia De Mexico|March 15, 2015
[Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management (Spanish version)]A Dignass, J O Lindsay, A Sturm, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodiesM Allez, S Vermeire, N Mozziconacci, et al.
Diagnostic and Interventional Imaging|April 8, 2015
Extra-intestinal malignancies in inflammatory bowel diseases: An update with emphasis on MDCT and MR imaging featuresA Dohan, S A Faraoun, M Barral, et al.
La Revue De Medecine Interne|January 14, 2024
French protocol for the diagnosis and management of hematopoietic stem cell transplantation in autoimmune diseasesD Farge, G Pugnet, M Allez, et al.
Pageof 5